SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Means Investment CO. Inc.

Means Investment CO. Inc. boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 106,773 shares of the exchange traded fund’s stock after acquiring an additional 1,407 shares during the period. SPDR S&P Biotech ETF makes up approximately 1.0% of Means Investment CO. Inc.’s portfolio, making the stock its 18th largest position. Means Investment CO. Inc.’s holdings in SPDR S&P Biotech ETF were worth $9,616,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at about $141,284,000. Mirae Asset Securities USA Inc. lifted its holdings in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares during the last quarter. Assetmark Inc. boosted its holdings in SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after purchasing an additional 588,489 shares during the period. Finally, Whittier Trust Co. raised its stake in SPDR S&P Biotech ETF by 3.3% during the third quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock worth $30,729,000 after acquiring an additional 9,976 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.9 %

SPDR S&P Biotech ETF stock opened at $92.67 on Monday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The company’s 50-day moving average price is $93.24 and its two-hundred day moving average price is $96.67. The stock has a market cap of $7.06 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.